Association of Katiparinah (Waist Circumference) and Visceral Adiposity Index in Medaj Granthi (Poly Cystic Ovarian Syndrome)
Not Applicable
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2022/11/047562
- Lead Sponsor
- CBPACS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Pre - diagnosed case of PCOS will be registered in group A.
2 Apparently healthy female will be registered in Group-B.
Exclusion Criteria
1 Pregnant women and Breast feeding female
2 Participants on lipid lowering (statins) and/or
contraceptives medicines(levonorgestrol tablet
levonorgestrol+ ethinyl estradiol tablets etc)
3 History of Hysterectomy and/or Oophorectomy 4 Female with thyroid disorder, hypertension,
diabetes and malnourished
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To estimate BMI <br/ ><br>To measure HDL, Triglycerides <br/ ><br>To measure Katiparinah( in angula) <br/ ><br>To calculate VAI all the readings will be taken at baseline only and the relationship will be established with PCOS <br/ ><br>Timepoint: All the readings will be taken at baseline only <br/ ><br> <br/ ><br>The readings will be analysed and relationship will be established with PCOS <br/ ><br>
- Secondary Outcome Measures
Name Time Method The result of the study may be helpful in early identification of people who could be patients of PCOS in the future only by measuring the waist circumference and VAI of the subjects.Timepoint: All the readings will be taken at baseline only and then compared with standard values. <br/ ><br> <br/ ><br>The readings will be analysed and relationship will be established with PCOS <br/ ><br>